CS logo
small CS logo
Centre Oscar Lambret; Service de Pediatrie

Lille, France
Centre de traitement du cancer à Lille

About Centre Oscar Lambret; Service de Pediatrie


"Le Centre Oscar Lambret de Lille, situé dans la région des Hauts-de-France, est une référence nationale en cancérologie. Hôpital universitaire, il a trois missions principales: le soin, la recherche et l'enseignement. Le Centre Oscar Lambret, créé en 1955, fait partie du groupe UNICANCER, qui réunit les 18 Centres de Lutte Contre le Cancer, établissements de santé privés d’intérêt collectif (ESPIC) exclusivement dédiés aux soins, à la recherche et à l’enseignement en cancérologie, et participant au service public hospitalier avec des tarifs conventionnels, sans aucun dépassement d’honoraires. Le Centre a été certifié par la Haute Autorité de Santé en septembre 2018."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centre Oscar Lambret; Service de Pediatrie


During the past decade, Centre Oscar Lambret; Service de Pediatrie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Centre Oscar Lambret; Service de Pediatrie


According to Clinical.Site data, the most researched conditions in "Centre Oscar Lambret; Service de Pediatrie" are "High Grade Glioma" (1 trials), "Sarcoma" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "Centre Oscar Lambret; Service de Pediatrie" in a lesser frequency.

Clinical Trials Intervention Types at Centre Oscar Lambret; Service de Pediatrie


Most popular intervention types in "Centre Oscar Lambret; Service de Pediatrie" are "Drug" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Belvarafenib" (1 trials), "Bevacizumab" (1 trials) and "Entrectinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centre Oscar Lambret; Service de Pediatrie


The vast majority of trials in "Centre Oscar Lambret; Service de Pediatrie" are 3 trials for "All" genders.

Clinical Trials Status at Centre Oscar Lambret; Service de Pediatrie


Currently, there are NaN active trials in "Centre Oscar Lambret; Service de Pediatrie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre Oscar Lambret; Service de Pediatrie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre Oscar Lambret; Service de Pediatrie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".